BTLS Biotalys NV

1.865USD1.700 EUR · EBR0.00%Mkt Cap: 84.74M USDP/E: —

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBO…

Key Statistics

Company
Market Cap84.74M USD
Enterprise Value61.40M USD
Revenue (TTM)291.75K USD
Gross Profit291.75K USD
Net Income (TTM)-17.28M USD
Revenue/Share0.0077 USD
Last Price1.865 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees37
CountryBE
SectorBasic Materials
IndustryAgricultural Inputs
ISINBE0974386188
Valuation
P/E (Trailing)—
P/E (Forward)-5.86
PEG—
EV/EBITDA-4.06
EV/Revenue210.44
P/S290.46
P/B4.46
EPS (TTM)-0.47 USD
EPS (Forward)-0.32 USD
52W Range
1.7114% of range5.429
52W High5.429 USD
52W Low1.711 USD
Profitability
Gross Margin100.00%
Oper. Margin-5606.02%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-130.21%
ROA-79.88%
ROIC-201.94%
ROCE-105.72%
Growth
Revenue Growth-40.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.00M USD
CapEx (TTM)199.62K USD
FCF Margin-2845.11%
FCF Yield-9.80%
Net Debt-11.85M USD
Net Debt/EBITDA0.78
Net Debt/FCF—
Balance Sheet
Debt/Equity0.31
Current Ratio2.93
Quick Ratio2.83
Book Value/Sh0.42 USD
Cash/Share0.39 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.155 USD
Upside (mean)+176.5%
Target Range3.729 USD – 6.581 USD
3.729+176.5% to mean6.581
# Analysts2
Ownership
Shares Out.45.45M
Float25.63M
Insiders27.44%
Institutions17.69%
Technical
SMA 502.035 (-8.4%)
SMA 2002.700 (-31.0%)
Beta1.49
S&P 52W Chg12.00%
Avg Vol (30d)19.71K
Avg Vol (10d)23.45K
Technical Indicators
RSI (14)39.4
MACD-0.0242
MACD Signal-0.0114
MACD Hist.-0.0128
BB Upper2.316 USD
BB Middle1.966 USD
BB Lower1.617 USD
BB Width35.55%
ATR (14)0.0885 USD
Vol Ratio (20d)0.27x

About Biotalys (EBR: BTLS)

›

Biotalys (EBR: BTLS) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Agricultural Inputs industry, part of the Basic Materials sector, and reports about 37 employees.

The shares were at 1.700 EUR on 19 November 2026, down 63.3% over 52 weeks. Its 52-week range is 1.560 EUR to 4.950 EUR: the price is 65.7% below the high and 9.0% above the low.

Its market capitalisation is 77.26M EUR.

Biotalys reports return on equity of -130.2% and revenue down 40.4% year over year.

It holds more cash than debt, a net cash position of 10.80M EUR. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 4.700 EUR is 176.5% above the current price. The next earnings report is expected on 18 March 2027.